CMP Scientific Corp. announced that it has signed a global co-marketing agreement with Agilent Technologies to provide an integrated CE-MS solution to life science and pharmaceutical industry. CMP Scientific develops, manufactures, and sells products and analytical instruments in life sciences, diagnostics, and applied markets.

CMP and Agilent will work together to implement new applications for the CE-MS system, which is a sensitive, alternative method to liquid chromatography-mass spectrometry (LC-MS) in mapping biological components. One of CMP's major products, EMASS-II CE-MS ion source integrates seamlessly with the Agilent's MS instruments to identify therapeutic monoclonal antibody (mAb) charge variants, and to analyze other diverse biological molecules.